Pharmacovigilance Outsourcing Market

Global Pharmacovigilance Outsourcing Market Size, Trends & Analysis - Forecasts to 2028 By Type (Adverse Drug Reaction Capture (ADR), Case Processing, Reporting and Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, and Enabling Architecture), By Service Provider (Contract Research Organization and Business Processing Outsourcing), By End User (Pharmaceutical Industry, Research Organization, and Others), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on June 18 2024 with the latest and most recent market numbers

Global Pharmacovigilance Outsourcing Market Size

The global pharmacovigilance outsourcing (PVO) market is expected to grow at a CAGR of 17.3% from 2023 to 2028. Pharmacovigilance means that the drug safety function execution is outsourced to a third party. Routine pharmacovigilance activities are outsourced, such as collecting ADR data, case processing, developing risk management plans, and submitting reports. Outsourcing helps save costs and management issues and improves on-demand facility access. Due to the specialization and systems, outsourced compliance services may give various advantages over internal compliance operations. Pharmacovigilance's primary goal is safeguarding its client's brand against a potential product recall from unfavourable medication interactions. The pharmacovigilance market is witnessing faster growth due to the rising outsourcing patterns among pharmaceutical businesses. Due to the availability of low-cost, high-quality labor in developing countries, many companies across various areas are outsourcing services for their research projects to reduce costs. This has increased the size of the outsourcing industry. The pharmacovigilance outsourcing market was valued at USD 2.49 billion in 2020 and is expected to grow significantly over the forecast period. 

Due to the disruption caused by the COVID-19 epidemic, the demand for medical services such as outsourcing pharmacovigilance has increased dramatically. Since several prospective treatments are utilized to treat infections brought on by coronaviruses, medical monitoring and safety reporting are crucial. The Uppsala Monitoring Center's VigiBase database, which houses individual case safety records, has already received reports on the likelihood of suspected adverse drug reactions for several of these medications. According to predictions, pandemics will increase demand for these services.

The main drivers of market growth are the increased emphasis on biopharmaceutical R&D, massive medication manufacturing, and the rise in cancer prevalence. Also, there are stringent rules for reporting negative medication interactions, and several businesses across the area that provide pharmacovigilance outsourcing services. Moreover, increased financing for clinical studies contributes to expanding the local pharmacovigilance outsourcing sector.

The market is challenged by the high risk associated with data security, a lack of global regulatory harmonization, and a lack of data standardization for adverse event collection.

global pharmacovigilance outsourcing market

Global Pharmacovigilance Outsourcing Market: By Type

Based on type, the global pharmacovigilance outsourcing market is segmented into adverse drug reaction capture (ADR), case processing, reporting and submission, report publishing, quality check, risk management, knowledge management, enabling architecture. It is expected that the case processing segment will be the largest segment in the forecast period.

Global Pharmacovigilance Outsourcing Market: By Service Provider

Among service providers, contract research organization segment is expected to be the largest segment over the forecast period. Contract research organisations segment is witnessing growth due to the rising demand for their services from small and medium-sized pharmaceutical businesses. Contract research organisations primarily take care of pre-marketing outsourcing needs of pharmaceutical companies, while business processing outsourcing firms take care of post-marketing needs.

Global Pharmacovigilance Outsourcing Market: By End User

Based on end user, the pharmaceutical industry segment is expected to hold the largest market share between 2023 and 2028. Pharma companies use outsourcing services in pharmacovigilance process to reduce fixed overhead costs and high upfront investments, free up more resources, and guarantee additional capacity. For small and medium-sized businesses, outsourcing pharmacovigilance is a financially wise decision. The research organization segment involving biotechnology will also account for a significant share in the global pharmacovigilance outsourcing market on the segmentation by end user.

asia pacific pharmacovigilance outsourcing market

Global Pharmacovigilance Outsourcing Market: By Region

North American is analyzed to be the largest region in the global pharmacovigilance outsourcing market during the forecast period. The North America Pharmacovigilance Outsourcing Market is driven by several key factors. Firstly, the growing complexity of the pharmaceutical industry, including an increase in the number of clinical trials and post-market surveillance requirements, has led pharmaceutical companies to seek specialized expertise in pharmacovigilance. Outsourcing allows these companies to access a pool of skilled professionals and advanced technologies, ensuring compliance with evolving regulations.

Secondly, the rising emphasis on patient safety and the need to monitor drug-related adverse events have put additional pressure on pharmaceutical firms to enhance their pharmacovigilance efforts. Outsourcing pharmacovigilance tasks to specialized service providers ensures a more comprehensive and efficient approach to adverse event monitoring, benefitting both patients and regulatory agencies.

Asia Pacific is analyzed to be the fastest growing region across the global pharmacovigilance outsourcing market with a CAGR of over 19.2%. Low-cost and high quality labor in China, Japan, India, and South Korea facilitate drives demand for pharmacovigilance outsourcing services.

Global Pharmacovigilance Outsourcing Market Share and Competitor Analysis

The key players operating in the market Accenture PLC., Bioclinica, Capgemini (IGate Corporation), Cognizant Technology Solutions Corporation, Ergomed Plc., Genpact Limited, International Business Machines Corporation, Icon Plc., IQVIA Holdings Inc. (Clintec), and Labcorp Drug Development (Covance).

Please note: This is not an exhaustive list of companies profiled in the report.

1          STRATEGIC INSIGHTS ON NEW REVENUE POCKETS

1.1    Strategic Opportunity & Attractiveness Analysis

1.1.1        Hot Revenue Pockets

1.1.2        Market Attractiveness Score

1.1.3        Revenue Impacting Opportunity

1.1.4        High Growing Region/Country

1.1.5        Competitor Analysis

1.1.6        Consumer Analysis

1.2    Global Market Estimates' View

1.3    Strategic Insights across Business Functions

1.3.1        For Chief Executive Officers

1.3.2        For Chief Marketing Officers

1.3.3        For Chief Strategy Officers

1.4    Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into

2          TECHNOLOGICAL TRENDS

2.1   Technological Adoption Rate

2.2   Current Trend Impact Analysis

2.3   Future Trend Impact Analysis

2.4   Data Metrics on Feed Stocks

3          GLOBAL MARKET OUTLOOK

3.1   Market Pyramid Analysis

3.1.1        Introduction

3.1.2        Adjacent Market Opportunities

3.1.3        Ancillary Market Opportunities

3.2   Demand Side Analysis

3.2.1        Market Drivers: Impact Analysis

3.2.2        Market Restraints: Impact Analysis

3.2.3        Market Opportunities: Impact Analysis

3.2.4        Market Challenges: Impact Analysis

3.3   Supply Side Analysis

3.3.1        Porter’s Five Forces Analysis

3.3.1.1 Threat of New Entrants

3.3.1.2 Threat of New Substitutes

3.3.1.3 Bargaining Power of Suppliers

3.3.1.4 Bargaining Power of Buyers

3.3.1.5 Intensity of Competitive Rivalry

3.3.2        SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)

3.3.2.1 Political Landscape

3.3.2.2 Economic Landscape

3.3.2.3 Social Landscape

3.3.2.4 Technology Landscape

3.3.3        Value Chain Analysis

3.3.4        Trend Analysis

3.3.5        Gap Analysis

3.3.6        Cost Analysis

4          GLOBAL PHARMACOVIGILANCE OUTSOURCING MARKET, BY TYPE

4.1   Introduction

4.2   Pharmacovigilance Outsourcing Market: Type Scope Key Takeaways

4.3   Revenue Growth Analysis, 2022 & 2028

4.4   Adverse Drug Reaction Capture (ADR)

4.4.1        Adverse Drug Reaction Capture (ADR) Market Estimates and Forecast, 2020-2028 (USD Million)

4.5   Case Processing

4.5.1        Case ProcessingMarket Estimates and Forecast, 2020-2028 (USD Million)

4.6   Reporting and Submission

4.7.1        Reporting and SubmissionMarket Estimates and Forecast, 2020-2028 (USD Million)

4.7   Report Publishing

4.7.1           Report Publishing Market Estimates and Forecast, 2020-2028 (USD Million)

4.8   Quality Check

4.8.1           Quality Check Market Estimates and Forecast, 2020-2028 (USD Million)

4.9   Risk Management

4.9.1           Risk Management Market Estimates and Forecast, 2020-2028 (USD Million)

4.10 Knowledge Management

4.10.1        Knowledge Management Market Estimates and Forecast, 2020-2028 (USD Million)

4.11 Enabling Architecture

4.11.1        Enabling Architecture Market Estimates and Forecast, 2020-2028 (USD Million)

5          GLOBAL PHARMACOVIGILANCE OUTSOURCING MARKET, BY SERVICE PROVIDER

5.1   Introduction

5.2   Pharmacovigilance Outsourcing Market: Service Provider Scope Key Takeaways

5.3   Revenue Growth Analysis, 2022 & 2028

5.4   Contract Research Organization

5.4.1        Contract Research Organization Market Estimates and Forecast, 2020-2028 (USD Million)

5.5   Business Processing Outsourcing

5.5.1        Business Processing Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

6          GLOBAL PHARMACOVIGILANCE OUTSOURCING MARKET, BY END USER

6.1   Introduction

6.2   Pharmacovigilance Outsourcing Market: End User Scope Key Takeaways

6.3   Revenue Growth Analysis, 2022 & 2028

6.4   Pharmaceutical Industry

6.4.1        Pharmaceutical Industry Market Estimates and Forecast, 2020-2028 (USD Million)

6.5   Research Organization

6.5.1        Research Organization Market Estimates and Forecast, 2020-2028 (USD Million)

6.6   Others

6.7.1        Others Market Estimates and Forecast, 2020-2028 (USD Million)

7          GLOBAL PHARMACOVIGILANCE OUTSOURCING MARKET, BY REGION

7.1   Introduction

7.2   North America Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.1        By Type

7.2.2        By Service Provider

7.2.3        By End User

7.2.4        By Country

7.2.4.1     U.S. Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.1.1        By Type

7.2.4.1.2        By Service Provider

7.2.4.1.3        By End User

7.2.4.2     Canada Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.2.1        By Type

7.2.4.2.2        By Service Provider

7.2.4.2.3        By End User

7.2.4.3     Mexico Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.2.4.3.1        By Type

7.2.4.3.2        By Service Provider

7.2.4.3.3        By End User

7.3   Europe Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.1        By Type

7.3.2        By Service Provider

7.3.3        By End User

7.3.4        By Country

7.3.4.1     Germany Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.1.1        By Type

7.3.4.1.2        By Service Provider

7.3.4.1.3        By End User

7.3.4.2     U.K. Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.2.1        By Type

7.3.4.2.2        By Service Provider

7.3.4.2.3        By End User

7.3.4.3     France Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.3.1        By Type

7.3.4.3.2        By Service Provider

7.3.4.3.3        By End User

7.3.4.4     Italy Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.4.1        By Type

7.3.4.4.2        By Service Provider

7.2.4.4.3        By End User

7.3.4.5     Spain Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.5.1        By Type

7.3.4.5.2        By Service Provider

7.2.4.5.3        By End User

7.3.4.6     Netherlands Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.7.1        By Type

7.3.4.7.2        By Service Provider

7.2.4.7.3        By End User

7.3.4.7     Rest of Europe Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.3.4.7.1        By Type

7.3.4.7.2        By Service Provider

7.2.4.7.3        By End User

7.4   Asia Pacific Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.1        By Type

7.4.2        By Service Provider

7.4.3        By End User

7.4.4        By Country

7.4.4.1     China Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.1.1        By Type

7.4.4.1.2        By Service Provider

7.4.4.1.3        By End User

7.4.4.2     Japan Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.2.1        By Type

7.4.4.2.2        By Service Provider

7.4.4.2.3        By End User

7.4.4.3     India Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.3.1        By Type

7.4.4.3.2        By Service Provider

7.4.4.3.3        By End User

7.4.4.4     South Korea Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.4.1        By Type

7.4.4.4.2        By Service Provider

7.4.4.4.3        By End User

7.4.4.5     Singapore Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.5.1        By Type

7.4.4.5.2        By Service Provider

7.4.4.5.3        By End User

7.4.4.6     Malaysia Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.7.1        By Type

7.4.4.7.2        By Service Provider

7.4.4.7.3        By End User

7.4.4.7     Thailand Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.7.1        By Type

7.4.4.7.2        By Service Provider

7.4.4.7.3        By End User

7.4.4.8     Indonesia Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.8.1        By Type

7.4.4.8.2        By Service Provider

7.4.4.8.3        By End User

7.4.4.9     Vietnam Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.9.1        By Type

7.4.4.9.2        By Service Provider

7.4.4.9.3        By End User

7.4.4.10  Taiwan Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.10.1 By Type

7.4.4.10.2 By Service Provider

7.4.4.10.3 By End User

7.4.4.11  Rest of Asia Pacific Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.4.4.11.1 By Type

7.4.4.11.2 By Service Provider

7.4.4.11.3 By End User

7.5   Middle East and Africa Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.1        By Type

7.5.2        By Service Provider

7.5.3        By End User

7.5.4        By Country

7.5.4.1     Saudi Arabia Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.1.1        By Type

7.5.4.1.2        By Service Provider

7.5.4.1.3        By End User

7.5.4.2     U.A.E. Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.2.1        By Type

7.5.4.2.2        By Service Provider

7.5.4.2.3        By End User

7.5.4.3     Israel Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.3.1        By Type

7.5.4.3.2        By Service Provider

7.5.4.3.3        By End User

7.5.4.4     South Africa Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.4.1        By Type

7.5.4.4.2        By Service Provider

7.5.4.4.3        By End User

7.5.4.5     Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.5.4.5.1        By Type

7.5.4.5.2        By Service Provider

7.5.4.5.2        By End User

7.6   Central & South America Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.7.1        By Type

7.7.2        By Service Provider

7.7.3        By End User

7.7.4        By Country

7.7.4.1     Brazil Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.7.4.1.1        By Type

7.7.4.1.2        By Service Provider

7.7.4.1.3        By End User

7.7.4.2     Argentina Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.7.4.2.1        By Type

7.7.4.2.2        By Service Provider

7.7.4.2.3        By End User

7.7.4.3     Chile Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.7.4.3.1        By Type

7.7.4.3.2        By Service Provider

7.7.4.3.3        By End User

7.7.4.4     Rest of Central & South America Pharmacovigilance Outsourcing Market Estimates and Forecast, 2020-2028 (USD Million)

7.7.4.4.1        By Type

7.7.4.4.2        By Service Provider

7.7.4.4.3        By End User

8          COMPETITIVE LANDCAPE

8.1   Company Market Share Analysis

8.2   Four Quadrant Positioning Matrix

8.2.1        Market Leaders

8.2.2        Market Visionaries

8.2.3        Market Challengers

8.2.4        Niche Market Players

8.3   Vendor Landscape

8.3.1        North America

8.3.2        Europe

8.3.3        Asia Pacific

8.3.4        Rest of the World

8.4   Company Profiles  

8.4.1        Accenture PLC

8.4.1.1 Business Description & Financial Analysis

8.4.1.2 SWOT Analysis

8.4.1.3 Products & Services Offered

8.4.1.4 Strategic Alliances between Business Partners

8.4.2        Bioclinica

8.4.2.1 Business Description & Financial Analysis

8.4.2.2 SWOT Analysis

8.4.2.3 Products & Services Offered

8.4.2.4 Strategic Alliances between Business Partners

8.4.3        Capgemini (IGate Corporation)

8.4.3.1 Business Description & Financial Analysis

8.4.3.2 SWOT Analysis

8.4.3.3 Products & Services Offered

8.4.3.4 Strategic Alliances between Business Partners

8.4.4        Cognizant Technology Solutions Corporation

8.4.4.1 Business Description & Financial Analysis

8.4.4.2 SWOT Analysis

8.4.4.3 Products & Services Offered

8.4.4.4 Strategic Alliances between Business Partners

8.4.5        Ergomed PLC.

8.4.5.1 Business Description & Financial Analysis

8.4.5.2 SWOT Analysis

8.4.5.3 Products & Services Offered

8.4.5.4 Strategic Alliances between Business Partners

8.4.6        GENPACT LIMITED

8.4.7.1 Business Description & Financial Analysis

8.4.7.2 SWOT Analysis

8.4.7.3 Products & Services Offered

8.4.7.4 Strategic Alliances between Business Partners

8.4.7        International Business Machines Corporation  

8.4.7.1 Business Description & Financial Analysis

8.4.7.2 SWOT Analysis

8.4.7.3 Products & Services Offered

8.4.8.4 Strategic Alliances between Business Partners

8.4.8        Icon PLC

8.4.8.1 Business Description & Financial Analysis

8.4.8.2 SWOT Analysis

8.4.8.3 Products & Services Offered

8.4.8.4 Strategic Alliances between Business Partners

8.4.9        IQVIA Holdings Inc. (Clintec)

8.4.9.1 Business Description & Financial Analysis

8.4.9.2 SWOT Analysis

8.4.9.3 Products & Services Offered

8.4.9.4 Strategic Alliances between Business Partners

8.4.10       Labcorp Drug Development (Covance)

8.4.10.1 Business Description & Financial Analysis

8.4.10.2 SWOT Analysis

8.4.10.3 Products & Services Offered

8.4.10.4 Strategic Alliances between Business Partners

8.4.11      Other Companies

8.4.11.1 Business Description & Financial Analysis

8.4.11.2 SWOT Analysis

8.4.11.3 Products & Services Offered

8.4.11.4 Strategic Alliances between Business Partners

9          RESEARCH METHODOLOGY

9.1   Market Introduction

9.1.1        Market Definition

9.1.2        Market Scope & SegPharmacovigilance Outsourcing Isolatestation

9.2   Information ProcurePharmacovigilance Outsourcing Isolatest

9.2.1        Secondary Research

9.2.1.1 Purchased Databases

9.2.1.2 GMEs Internal Data Repository

9.2.1.3 Secondary Resources & Third Party Perspectives

9.2.1.4 Company Information Sources

9.2.2        Primary Research

9.2.2.1 Various Types of Respondents for Primary Interviews

9.2.2.2 Number of Interviews Conducted throughout the Research Process

9.2.2.3 Primary Stakeholders

9.2.2.4 Discussion Guide for Primary Participants

9.2.3        Expert Panels

9.2.3.1 Expert Panels Across 30+ Industry

9.2.4        Paid Local Experts

9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region

9.3   Market Estimation

9.3.1        Top-Down Approach

9.3.1.1 Macro-Economic Indicators Considered

9.3.1.2 Micro-Economic Indicators Considered

9.3.2        Bottom Up Approach

9.3.2.1 Company Share Analysis Approach

9.3.2.2 Estimation of Potential Product End User

9.4   Data Triangulation

9.4.1        Data Collection

9.4.2        Time Series, Cross Sectional & Panel Data Analysis

9.4.3        Cluster Analysis

9.5   Analysis and Output

9.5.1        Inhouse AI Based Real Time Analytics Tool

9.5.2        Output From Desk & Primary Research

9.6   Research Assumptions & Limitations

9.7.1        Research Assumptions

9.7.2        Research Limitations

LIST OF TABLES

1 Global Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Mllion)

2 Adverse Drug Reaction Capture (ADR) Market, By Region, 2020-2028 (USD Mllion)

3 Case ProcessingMarket, By Region, 2020-2028 (USD Mllion)          

4 Reporting and SubmissionMarket, By Region, 2020-2028 (USD Mllion)    

5 Report Publishing Market, By Region, 2020-2028 (USD Mllion)

6 Quality Check, By Region, 2020-2028 (USD Mllion)

7 Risk Management, By Region, 2020-2028 (USD Mllion)

8 Knowledge Management, By Region, 2020-2028 (USD Mllion)

9 Enabling Architecture, By Region, 2020-2028 (USD Mllion)

10 Global Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Mllion)

11 Contract Research Organization Market, By Region, 2020-2028 (USD Mllion)    

12 Business Processing Outsourcing Market, By Region, 2020-2028 (USD Mllion)

13 Global Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Mllion)

14 Pharmaceutical Industry Market, By Region, 2020-2028 (USD Mllion)     

15 Research Organization Market, By Region, 2020-2028 (USD Mllion)          

16 Others Market, By Region, 2020-2028 (USD Mllion)

17 Regional Analysis, 2020-2028 (USD Mllion)

18 North America Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

19 North America Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

20 North America Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

21 North America Pharmacovigilance Outsourcing Market, By Country, 2020-2028 (USD Million)

22 U.S Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

23 U.S Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

24 U.S Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

25 Canada Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

26 Canada Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

27 Canada Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

28 Mexico Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

29 Mexico Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

30 Mexico Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

31 Europe Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

32 Europe Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

33 Europe Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

34 Germany Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

35 Germany Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

36 Germany Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

37 UK Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

38 UK Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

39 UK Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

40 France Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

41 France Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

42 France Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

43 Italy Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

44 Italy Pharmacovigilance Outsourcing Market, By T Service Provider Type, 2020-2028 (USD Million)

45 Italy Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

46 Spain Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

47 Spain Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

48 Spain Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

49 Rest Of Europe Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

50 Rest Of Europe Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

51 Rest of Europe Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

52 Asia Pacific Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

53 Asia Pacific Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

54 Asia Pacific Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

55 Asia Pacific Pharmacovigilance Outsourcing Market, By Country, 2020-2028 (USD Million)

56 China Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

57 China Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

58 China Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

59 India Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

60 India Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

61 India Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

62 Japan Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

63 Japan Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

64 Japan Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

65 South Korea Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

66 South Korea Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

67 South Korea Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

68 Middle East and Africa Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

69 Middle East and Africa Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

70 Middle East and Africa Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

71 Middle East and Africa Pharmacovigilance Outsourcing Market, By Country, 2020-2028 (USD Million)

72 Saudi Arabia Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

73 Saudi Arabia Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

74 Saudi Arabia Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

75 UAE Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

76 UAE Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

77 UAE Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

78 Central & South America Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

79 Central & South America Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

80 Central & South America Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

81 Central & South America Pharmacovigilance Outsourcing Market, By Country, 2020-2028 (USD Million)

82 Brazil Pharmacovigilance Outsourcing Market, By Type, 2020-2028 (USD Million)

83 Brazil Pharmacovigilance Outsourcing Market, By Service Provider, 2020-2028 (USD Million)

84 Brazil Pharmacovigilance Outsourcing Market, By End User, 2020-2028 (USD Million)

85 Accenture PLC: Products & Services Offering

86 Bioclinica: Products & Services Offering  

87 Capgemini (IGate Corporation): Products & Services Offering     

88 Cognizant Technology Solutions Corporation: Products & Services Offering

89 Ergomed PLC.: Products & Services Offering          

90 GENPACT LIMITED: Products & Services Offering     

91 International Business Machines Corporation : Products & Services Offering

92 Icon PLC: Products & Services Offering      

93 IQVIA Holdings Inc. (Clintec), Inc: Products & Services Offering 

94 Labcorp Drug Development (Covance): Products & Services Offering    

95 Other Companies: Products & Services Offering  

LIST OF FIGURES

1 Global Pharmacovigilance Outsourcing Market Overview

2 Global Pharmacovigilance Outsourcing Market Value From 2020-2028 (USD Mllion)

3 Global Pharmacovigilance Outsourcing Market Share, By Type (2022)

4 Global Pharmacovigilance Outsourcing Market Share, By Service Provider (2022)

5 Global Pharmacovigilance Outsourcing Market Share, By End User (2022)

6 Global Pharmacovigilance Outsourcing Market, By Region (Asia Pacific Market)

7 Technological Trends In Global Pharmacovigilance Outsourcing Market

8 Four Quadrant Competitor Positioning Matrix

9 Impact Of Macro & Micro Indicators On The Market

10 Impact Of Key Drivers On The Global Pharmacovigilance Outsourcing Market

11 Impact Of Challenges On The Global Pharmacovigilance Outsourcing Market

12 Porter’s Five Forces Analysis

13 Global Pharmacovigilance Outsourcing Market: By Type Scope Key Takeaways

14 Global Pharmacovigilance Outsourcing Market, By Type Segment: Revenue Growth Analysis

15 Adverse Drug Reaction Capture (ADR) Market, By Region, 2020-2028 (USD Mllion)

16 Case ProcessingMarket, By Region, 2020-2028 (USD Mllion)

17 Reporting and Submission Market, By Region, 2020-2028 (USD Mllion)

18 Report Publishing Market, By Region, 2020-2028 (USD Mllion)

19 Quality Check Market, By Region, 2020-2028 (USD Mllion)

20 Risk Management Market, By Region, 2020-2028 (USD Mllion)

21 Knowledge Management Market, By Region, 2020-2028 (USD Mllion)

22 Enabling Architecture Market, By Region, 2020-2028 (USD Mllion)  

23 Global Pharmacovigilance Outsourcing Market: By Service Provider Scope Key Takeaways

24 Global Pharmacovigilance Outsourcing Market, By Service Provider Segment: Revenue Growth Analysis

25 Contract Research Organization Market, By Region, 2020-2028 (USD Mllion)      

26 Business Processing Outsourcing Market, By Region, 2020-2028 (USD Mllion)

27 Global Pharmacovigilance Outsourcing Market: By End User Scope Key Takeaways

28 Global Pharmacovigilance Outsourcing Market, By End User Segment: Revenue Growth Analysis

29 Pharmaceutical Industry Market, By Region, 2020-2028 (USD Mllion)

30 Research Organization Market, By Region, 2020-2028 (USD Mllion)

31 Others Market, By Region, 2020-2028 (USD Mllion)

32 Regional Segment: Revenue Growth Analysis

33 Global Pharmacovigilance Outsourcing Market: Regional Analysis

34 North America Pharmacovigilance Outsourcing Market Overview

35 North America Pharmacovigilance Outsourcing Market, By Type

36 North America Pharmacovigilance Outsourcing Market, By Service Provider

37 North America Pharmacovigilance Outsourcing Market, By End User

38 North America Pharmacovigilance Outsourcing Market, By Country

39 U.S. Pharmacovigilance Outsourcing Market, By Type

40 U.S. Pharmacovigilance Outsourcing Market, By Service Provider

41 U.S. Pharmacovigilance Outsourcing Market, By End User

42 Canada Pharmacovigilance Outsourcing Market, By Type

43 Canada Pharmacovigilance Outsourcing Market, By Service Provider

44 Canada Pharmacovigilance Outsourcing Market, By End User

45 Mexico Pharmacovigilance Outsourcing Market, By Type

46 Mexico Pharmacovigilance Outsourcing Market, By Service Provider

47 Mexico Pharmacovigilance Outsourcing Market, By End User

48 Four Quadrant Positioning Matrix

49 Company Market Share Analysis

50 Accenture PLC: Company Snapshot

51 Accenture PLC: SWOT Analysis

52 Accenture PLC: Geographic Presence

53 Bioclinica: Company Snapshot

54 Bioclinica: SWOT Analysis

55 Bioclinica: Geographic Presence

56 Capgemini (IGate Corporation): Company Snapshot

57 Capgemini (IGate Corporation): SWOT Analysis

58 Capgemini (IGate Corporation): Geographic Presence

59 Cognizant Technology Solutions Corporation: Company Snapshot

60 Cognizant Technology Solutions Corporation: Swot Analysis

61 Cognizant Technology Solutions Corporation: Geographic Presence

62 Ergomed PLC.: Company Snapshot

63 Ergomed PLC.: SWOT Analysis

64 Ergomed PLC.: Geographic Presence

65 GENPACT LIMITED: Company Snapshot

66 GENPACT LIMITED: SWOT Analysis

67 GENPACT LIMITED: Geographic Presence

68 International Business Machines Corporation : Company Snapshot

69 International Business Machines Corporation : SWOT Analysis

70 International Business Machines Corporation : Geographic Presence

71 Icon PLC: Company Snapshot

72 Icon PLC: SWOT Analysis

73 Icon PLC: Geographic Presence

74 IQVIA Holdings Inc. (Clintec), Inc.: Company Snapshot

75 IQVIA Holdings Inc. (Clintec), Inc.: SWOT Analysis

76 IQVIA Holdings Inc. (Clintec), Inc.: Geographic Presence

77 Labcorp Drug Development (Covance): Company Snapshot

78 Labcorp Drug Development (Covance): SWOT Analysis

79 Labcorp Drug Development (Covance): Geographic Presence

80 Other Companies: Company Snapshot

81 Other Companies: SWOT Analysis

82 Other Companies: Geographic Presence

The Global Pharmacovigilance Outsourcing Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Pharmacovigilance Outsourcing Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The global pharmacovigilance outsourcing market is expected to grow at a CAGR of 17.3% from 2023 to 2028.
The key players operating in the market are Accenture PLC., Bioclinica, Capgemini (IGate Corporation), Cognizant Technology Solutions Corporation, Ergomed Plc., Genpact Limited, International Business Machines Corporation, Icon Plc., IQVIA Holdings Inc. (Clintec), and Labcorp Drug Development (Covance).
The global pharmacovigilance outsourcing market is expected to gain opportunities due to the growing demand for outsourcing clinical trials and others to save costs and work efficiently.
The increased focus on biopharmaceutical R&D, rising drug manufacturing, and increasing prevalence of cancer are the main drivers for the market growth. Also, there are stringent rules for reporting negative medication interactions and several businesses across the area that provide pharmacovigilance outsourcing services.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius